Main Article Content
Amniotic Membrane Therapy, Ocular Surface Disease
The goal of this publication is to show the many uses for AMs in treating ocular surface disease and to provide a resource for their use in clinical practice.
2. Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2001;45(Suppl. 2):S203–10.
3. Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul. Surf 2013;11:246–58.
4. Muri M, Moshirfar M. Birdsong O. 2018. Amniotic membrane extract and eye drops: a review of literature and clinical application, Clin Ophthalmol 2018;12:1105–12.